Results 51 to 60 of about 2,851 (84)

Fracture Resistance of Reattached Tooth Fragments: Influence of Adhesive Curing Mode and Composite Viscosity

Journal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective To evaluate the influence of adhesive curing mode and composite viscosity type on the fracture resistance of reattached anterior teeth using the internal groove technique. Materials and Methods Seventy‐two extracted human maxillary central incisors were fractured using a standardized protocol and randomly assigned to six groups ...
Esra Yildirim‐Manav, Sema Yazici‐Akbiyik, Sedanur Sakalli, Cansu Yikici‐Çöl   +3 more
wiley   +1 more source

Distinct roles for neuropilin1 and neuropilin2 during mouse corneal innervation. [PDF]

PLoS ONE, 2012
Trigeminal sensory innervation of the cornea is critical for protection and synthesis of neuropeptides required for normal vision. Little is known about axon guidance during mammalian corneal innervation.
Chelsey C McKenna, Ravi P Munjaal, Peter Y Lwigale   +2 more
doaj   +1 more source

Repair Bond Strength of Self‐Cure Bulk‐Fill Composites: Influence of Substrate Composition, Surface Conditioning, and Repair Material Type

Journal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective This in vitro study aimed to evaluate the effects of substrate composition, surface conditioning protocol, and repair material type on the repair shear bond strength (SBS) of an aged self‐cure bulk‐fill resin composite. Materials and Methods A total of 80 specimens were fabricated using two substrate compositions of a self‐cure bulk ...
Esra Yildirim‐Manav, Sema Yazici‐Akbiyik, Sedanur Sakalli, Simge Canatan‐Keskin, Sıla Nur Usta   +4 more
wiley   +1 more source

Risk factors for cholera mortality: A scoping review

Tropical Medicine &International Health, Volume 30, Issue 5, Page 332-350, May 2025.
Abstract Objectives Cholera is an easily treatable disease, but many people are still unnecessarily dying from it. To improve current case management practices and prevent mortality requires a comprehensive understanding of who is at higher risk of dying.
Despina Pampaka, Kathryn Alberti, David Olson, Iza Ciglenecki, Philippe Barboza   +4 more
wiley   +1 more source

Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet‐induced obesity

The Journal of Physiology, EarlyView.
Abstract figure legend Four weeks of semaglutide treatment causes significant reductions in total body weight, fat mass, lean mass, and grip strength in mice with diet induced obesity. Mice treated with semaglutide lost a greater amount of total body weight and fat mass compared to mice fed fed a calorie matched diet.
S. Jeromson, B. Baranowski, M. Akcan, B. D. Waters, K. Eisner, A. Bellucci, S. Trang, A. Abolhassani, M. A. Tello‐Palencia, A. Schweitzer, B. Stefanska, C. J. Mitchell, David C. Wright   +12 more
wiley   +1 more source

Preclinical Toxicity Screening of Sodium Dodecanoyloxybenzenesulfonate (LOBS) as a New Alternative Biocide Using In Vitro and In Vivo Models

Environmental Toxicology, Volume 41, Issue 9, Page 670-681, September 2026.
ABSTRACT Sodium hypochlorite is a well‐established biocide extensively used in both living and industrial environments; however, exposure to it or improper handling can harm the human body and the environment. Thus, safer alternatives to sodium hypochlorite are required.
Seung Eui Min, Seunghee Oh, Min Seong Jang, Kang‐Hyun Han   +3 more
wiley   +1 more source

Neurodevelopmental Phenotypes and Brain Anomalies in Individuals With Heterozygous SEMA6A Variants

Clinical Genetics, Volume 110, Issue 3, Page 325-335, September 2026.
SEMA6A plays a role in cell migration and axon guidance in the developing central nervous system. Phenotypes seen in eleven individuals heterozygous for SEMA6A variants included developmental delay, intellectual disability, autism/autistic behaviors, behavioral abnormalities, attention disorders, hypotonia, and brain anomalies.
Evan Burchfiel, Xiaonan Zhao, Nichole M. Owen, Tia Gordon, Mahshid S. Azamian, Eric C. Kao, Fan Xia, Xi Luo, Jill A. Rosenfeld, Seema R. Lalani, Allison P. Ortega, Steven B. Bleyl, Florence Petit, Sulekha Rajagopolan, Bénédicte Demeer, Meredith K. Gillespie, Lijia Huang, Matthew Osmond, Kym M. Boycott, Kyra E. Stuurman, Marjon A. van Slegtenhorst, Haley Soller, Céline Jost, Aurore Garde, Hana Safraou, Laurence Faivre, Victor Faundes, Daryl A. Scott   +27 more
wiley   +1 more source

Effects of Incretin‐Based Therapies, Diet and Exercise Interventions, and Bariatric Surgery on Fat‐Free Mass in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 7737-7751, September 2026.
ABSTRACT Background Maintaining fat‐free mass (FFM) during weight loss is important to maintain a healthy body composition. This review examined changes in FFM during weight loss induced by diet and exercise interventions, incretin‐based therapies, and bariatric surgery, and assessed whether the relative loss of FFM differs by weight‐loss modality ...
Laura Busk‐Cirera, Ida Ørum Carlsen, Lærke Bruun Madsen, Rasmus Michael Sandsdal, Emma Jensen, Simon Birk Kjær Jensen, Signe Sørensen Torekov   +6 more
wiley   +1 more source

Rane disfunkcionalne kognitivne šeme: povezanost sa afektivnom vezanošću u bliskim relacijama u mlađem odraslom dobu

Primenjena Psihologija, 2008
Disfunkcionalne šeme razvijaju se rano u detinjstvu kombinacijom vulnera-bilnog temperamenta i disfunkcionalnih iskustava u prvim bliskim vezama unutar porodice.
Ivana Mihić, Marija Zotović, Jelica Petrović   +2 more
doaj   +1 more source

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8347-8358, September 2026.
ABSTRACT Aims Orforglipron is a novel small‐molecule, once daily oral non‐peptide GLP‐1 receptor agonist. The hepatic safety profile in adults with obesity or overweight and/or type 2 diabetes (T2D) across seven orforglipron Phase 3 clinical trials was assessed.
Sean Wharton, Adam Stefanski, Jiaxun Chen, Girish Rao, Elvis Asare Twum, Max Denning   +5 more
wiley   +1 more source